Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SAB Biotherapeutics, Inc. | 150,000 | reported | 16 Dec 2025 | tx 5+3,062,142−1,800 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Dec 2025 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 150,000 | 0.00 USD | deriv |
| 01 Nov 2024 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 35,000 | 0.00 USD | deriv |
| 01 Nov 2024 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 24 Nov 2023 | EXERCISE | SAB Biotherapeutics, Inc. | 2,857,142 | — | |
| 24 Nov 2023 | EXERCISE | SAB Biotherapeutics, Inc. | 1,800 | 1000.00 USD | deriv |